Volume 13, Number 9—September 2007
Dispatch
Parenteral Transmission of the Novel Human Parvovirus PARV4
Table 2
Virus detected and risk group | Lymphoid tissue |
|
---|---|---|
Positive | Negative | |
B19 (all risk groups) | ||
Bone marrow | ||
Positive | 27 | 1 |
Negative | 3 | 29 |
PARV4 (IDUs and persons with hemophilia) | ||
Bone marrow | ||
Positive | 14 | 1 |
Negative | 2 | 21 |
*IDUs, injection drug users.
Page created: July 01, 2010
Page updated: July 01, 2010
Page reviewed: July 01, 2010
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.